Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0.1
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
<0.1
General Information
Version
2.0
Revision date
2025-09-03
Product name
Reveal 3-D Food Buffer
Manufacturer Name
Neogen Corporation
Emergency telephone
1-800-498-5743, 1-651-523-0318, 1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
Neogen Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
sds@neogen.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May cause an allergic skin reaction
Hazard pictograms
GHS07
Signal word
Warning
Contains
1,2-Benzisothiazol-3(2H)-one
Hazard statements
H317 - May cause an allergic skin reaction.
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P321 - Specific treatment (see supplemental first aid instruction on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Di-sodium hydrogen phosphate (10028-24-7), Sodium chloride (7647-14-5), Dipropylene regulation, in accordance with Annex XIII glycol (25265-71-8), 1,2-Benzisothiazol-3(2H)-one (2634-33-5)(¹), Sodium hydroxide (1310-73-2)(¹) Substance(s) not meeting the vPvB criteria of REACH Di-sodium hydrogen phosphate (10028-24-7), Sodium chloride (7647-14-5), Dipropylene regulation, in accordance with Annex XIII glycol (25265-71-8), 1,2-Benzisothiazol-3(2H)-one (2634-33-5)(¹), Sodium hydroxide (1310-73-2)(¹) (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction.